Authors: Alice Bough (Future Science Group)
Researchers at King’s College London (UK) will be studying the potential of the cannabis-based drug Sativex® to treat behavioral changes associated with dementia. Alzheimer’s Research UK (Cambridge, UK) are investing approximately £300,000 in this pioneering clinical trial that investigates whether the drug is effective against symptoms of agitation and aggression.
In addition to memory loss and cognitive impairment, people living with dementia can also experience behavioral changes. “Many people with Alzheimer’s can become agitated or aggressive, and this can pose difficulties for the person with the condition and those closest to them,” commented Dag Aarsland (King’s College London), who is the lead researcher of the clinical trial.